Hypovitaminosis D in Patients with Type 2 Diabetes Mellitus: a Relation to Disease Control and Complications

Overview

Journal ISRN Endocrinol

Specialty Endocrinology

Date 2013 Nov 20

PMID 24251044

Citations 40

Authors

Hala Ahmadieh

Sami T Azar

Najla Lakkis

Asma Arabi

Affiliations

Soon will be listed here.

Abstract

Aims. This study aims at assessing the relationship between 25 (OH) vitamin D (25-OHD) levels and microvascular complications in patients with type 2 diabetes mellitus (DM2). Methods. 136 patients (59 ± 11 years) with DM2 (disease duration 8.6 ± 7 years) participated in this cross-sectional study. Anthropometric data, HbA1c, 25-OHD levels, serum creatinine, and urine microalbumin/creatinine ratio were collected. Dilated retinal exam was performed, and diabetic neuropathy was assessed using the United Kingdom Screening Score. Results. Serum 25-OHD correlated negatively with HbA1c (r = -0.20, P = 0.049). Mean 25-OHD levels were lower in subjects with diabetic retinopathy compared to those without retinopathy (12.3 ± 5.5 versus 21.8 ± 13.7, P < 0.001) and lower in subjects with diabetic neuropathy compared to those without neuropathy (16.4 ± 10.4 versus 23.5 ± 14.5, P = 0.004). After adjustment for BMI, diabetes duration, and smoking, 25-OHD was an independent predictor of HbA1c ( β -0.14; P = 0.03). After adjustment for HbA1c, age, smoking, BMI and disease duration, 25-OHD were independent predictors for diabetic retinopathy: OR 2.8 [95% CI 2.1-8.0] and neuropathy: OR 4.5 [95% CI 1.6-12] for vitamin D < 20 versus vitamin D ≥ 20 ng/mL. Conclusion. Low serum 25-OHD level was an independent predictor of HbA1c, diabetic neuropathy, and diabetic retinopathy in patients with DM2.

Citing Articles

Vitamin D Supplementation: Shedding Light on the Role of the Sunshine Vitamin in the Prevention and Management of Type 2 Diabetes and Its Complications.

Vasdeki D, Tsamos G, Dimakakos E, Patriarcheas V, Koufakis T, Kotsa K Nutrients. 2024; 16(21).

PMID: 39519484 PMC: 11547801. DOI: 10.3390/nu16213651.

Vitamin D Deficiency Participates in Depression of Patients with Diabetic Peripheral Neuropathy by Regulating the Expression of Pro-Inflammatory Cytokines.

Zhou J, Li D, Wang Y Neuropsychiatr Dis Treat. 2024; 20:389-397.

PMID: 38436043 PMC: 10908276. DOI: 10.2147/NDT.S442654.

Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review.

Milluzzo A, Barchitta M, Maugeri A, Magnano San Lio R, Favara G, Mazzone M Nutrients. 2022; 14(20).

PMID: 36297113 PMC: 9612209. DOI: 10.3390/nu14204430.

The Association between Vitamin D Hypovitaminosis and Cardiovascular Disease Risk in Saudi Diabetic Patients Type II.

ALrefai A, Elsalamony E, Fatani S, Kasemy Z, Fatani A, Mohamed Kamel H Biochem Res Int. 2022; 2022:6097864.

PMID: 36193546 PMC: 9525733. DOI: 10.1155/2022/6097864.

Association between Circulating Levels of 25-Hydroxyvitamin D and Matrix Metalloproteinase-10 (MMP-10) in Patients with Type 2 Diabetes.

Abasheva D, Dolcet-Negre M, Fernandez-Seara M, Mora-Gutierrez J, Orbe J, Escalada F Nutrients. 2022; 14(17).

PMID: 36079742 PMC: 9458174. DOI: 10.3390/nu14173484.

References

Lappe J, Travers-Gustafson D, Davies K, Recker R, Heaney R . Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007; 85(6):1586-91. DOI: 10.1093/ajcn/85.6.1586. View

Patrick P, Visintainer P, Shi Q, Weiss I, Brand D . Vitamin D and retinopathy in adults with diabetes mellitus. Arch Ophthalmol. 2012; 130(6):756-60. DOI: 10.1001/archophthalmol.2011.2749. View

Young M, Boulton A, Macleod A, Williams D, Sonksen P . A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993; 36(2):150-4. DOI: 10.1007/BF00400697. View

Isaia G, Giorgino R, Adami S . High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care. 2001; 24(8):1496. DOI: 10.2337/diacare.24.8.1496. View

Nagpal S, Na S, Rathnachalam R . Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005; 26(5):662-87. DOI: 10.1210/er.2004-0002. View

Karatekin G, Kaya A, Salihoglu O, Balci H, Nuhoglu A . Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr. 2007; 63(4):473-7. DOI: 10.1038/sj.ejcn.1602960. View

Girach A, Manner D, Porta M . Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract. 2006; 60(11):1471-83. DOI: 10.1111/j.1742-1241.2006.01175.x. View

Cantorna M . Vitamin D and multiple sclerosis: an update. Nutr Rev. 2008; 66(10 Suppl 2):S135-8. PMC: 3712128. DOI: 10.1111/j.1753-4887.2008.00097.x. View

Inukai T, Fujiwara Y, Tayama K, Aso Y, Takemura Y . Alterations in serum levels of 1 alpha,25(OH)2 D3 and osteocalcin in patients with early diabetic nephropathy. Diabetes Res Clin Pract. 1997; 38(1):53-9. DOI: 10.1016/s0168-8227(97)00090-9. View

10.

Mohr S . A brief history of vitamin d and cancer prevention. Ann Epidemiol. 2009; 19(2):79-83. DOI: 10.1016/j.annepidem.2008.10.003. View

11.

Suzuki A, Kotake M, Ono Y, Kato T, Oda N, Hayakawa N . Hypovitaminosis D in type 2 diabetes mellitus: Association with microvascular complications and type of treatment. Endocr J. 2006; 53(4):503-10. DOI: 10.1507/endocrj.k06-001. View

12.

Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M . Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med. 2009; 179(8):630-6. DOI: 10.1164/rccm.200810-1576PP. View

13.

Albert D, Scheef E, Wang S, Mehraein F, Darjatmoko S, Sorenson C . Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophthalmol Vis Sci. 2007; 48(5):2327-34. DOI: 10.1167/iovs.06-1210. View

14.

Kendrick J, Targher G, Smits G, Chonchol M . 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2008; 205(1):255-60. DOI: 10.1016/j.atherosclerosis.2008.10.033. View

15.

Lee P, Chen R . Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med. 2008; 168(7):771-2. DOI: 10.1001/archinte.168.7.771. View

16.

Sherwin R, Jastreboff A . Year in diabetes 2012: The diabetes tsunami. J Clin Endocrinol Metab. 2012; 97(12):4293-301. PMC: 3513534. DOI: 10.1210/jc.2012-3487. View

17.

Mata-Cases M, De Prado-Lacueva C, Salido-Valencia V, Fernandez-Bertolin E, Casermeiro-Cortes J, Garcia-Duran M . Incidence of complications and mortality in a type 2 diabetes patient cohort study followed up from diagnosis in a primary healthcare centre. Int J Clin Pract. 2011; 65(3):299-307. DOI: 10.1111/j.1742-1241.2010.02503.x. View

18.

Cardoso C, Salles G . Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients. J Diabetes Complications. 2008; 22(3):164-70. DOI: 10.1016/j.jdiacomp.2007.02.004. View

19.

Mattila C, Knekt P, Mannisto S, Rissanen H, Laaksonen M, Montonen J . Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care. 2007; 30(10):2569-70. DOI: 10.2337/dc07-0292. View

20.

Staud R . Vitamin D: more than just affecting calcium and bone. Curr Rheumatol Rep. 2005; 7(5):356-64. DOI: 10.1007/s11926-005-0020-0. View